peter attia on semaglutide 246 - AMA #45: Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent Semaglutide Insights | Ask Huberman

Virtually every lipid and lipoprotein is affected by insulin resistance and diabetes mellitus, but control of hyperglycemia is unlikely to correct existing dyslipidemia

Along with novel immunology agents, we expect GLP-1 drugs to realign the pharmaceutical market

His patients who regularly fly and drive to The Naderi Center from all over the country have already known how great he is for his unique style of Botox and filler injections

And what Category 1 status would mean for compounding pharmacies and telehealth clinics

Clinical trials have shown positive results regarding the efficacy of AOD-9604 for weight loss in humans, with one study reporting an average loss of 2.6 kg over 12 weeks, compared to 0.8 kg in the placebo group

Key findings: Prescribing trends Using a subset of Truveta Data, Truveta Research identified people who were prescribed a GLP-1 RA between January 01, 2019 and December 31, 2025